Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S013 - Nails

Friday, February 16; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Discuss the utility of dermoscopy, advanced imaging techniques, and molecular testing for melanonychia.
  • Assess the relationship between nail unit psoriasis and psoriatic arthritis.
  • Identify the dissapearing nail bed and factors which cause it.

Description

This Symposium delivers the most up to date information by internationally renowned speakers on the essential areas of nail disorders including onychomycosis, inflammatory disorders, benign and malignant nail tumors, nail surgery, and basic science related to nail disorders. A focus on the most cutting edge information on the evaluation of melanonychia through dermoscopy, advanced imaging, and molecular diagnostic techniques is also included. A portion of the program is dedicated to nail experts presenting cases with pearls from their best cases.

Disclosures

  • Adigun, Chris, MD: Celgene Corporation – Speaker/Faculty Education(H); Cipher Pharmaceuticals – A(H); Ortho Dermatologics – SP(H); Sandoz, a Novartis company – A(H); Sciton Inc. – SP(H); YouVeeShield – C(SO);
  • Baran, Robert L., MD: no financial relationships exist with commercial interests.
  • Jellinek, Nathaniel J., MD: no financial relationships exist with commercial interests.
  • Knackstedt, Thomas Joachim, MD: no financial relationships exist with commercial interests.
  • Lee, Dong-Youn, MD, PhD: no financial relationships exist with commercial interests.
  • Lipner, Shari, MD, PhD: Bako Diagnostics – C(H); MOE Medical Devices LLC – I(Grants/Research Funding);
  • Rich, Phoebe, MD: AbbVie – I(Grants/Research Funding); Allergan, Inc – I(Grants/Research Funding); Anacor Pharmaceuticals, Inc. – I(Grants/Research Funding); Boehringer Ingelheim – I(Grants/Research Funding); Cassiopea SpA – I(Grants/Research Funding); Dermira – I(Grants/Research Funding); DUSA Pharmaceuticals, Inc – I(Grants/Research Funding); Eli Lilly and Company – I(Grants/Research Funding); Foamix – I(Grants/Research Funding); Galderma Laboratories, L.P. – I(Grants/Research Funding); Janssen-Ortho Inc. – I(Grants/Research Funding); Kadmon Corporation, LLC – I(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – I(Grants/Research Funding); Merck & Co., Inc – I(Grants/Research Funding); Moberg Derma – I(Grants/Research Funding); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Ranbaxy Laboratories Limited – I(Grants/Research Funding); Sandoz, a Novartis company – I(Grants/Research Funding); Valeant Pharmaceuticals International – I(Grants/Research Funding); Viomet – I(Grants/Research Funding);
  • Rigopoulos, Dimitris, MD: no financial relationships exist with commercial interests.
  • Ruben, Beth S., MD: UpToDate, Inc – O(Fees);
  • Rubin, Adam, MD: Lippincott Williams & Wilkins – O(OB); Myriad Genetics Inc – A(H); Springer Publishing – O(OB); United Health Care – A(H); University of Pennsylvania – E(S);
  • Shemer, Avner, MD: AbbVie – Speaker/Faculty Education(Fees); AMI Technologies – C(Fees); Ex-It Medical Devices Limited – C(Fees); Janssen Biotech – Speaker/Faculty Education(Fees); NeoPharm Israel – C(Fees); Novartis – Speaker/Faculty Education(Fees); Perrigo Company – Speaker/Faculty Education(Fees); Pfizer Inc. – Speaker/Faculty Education(Fees);
  • Starace, Michela, MD, PhD: no financial relationships exist with commercial interests.
  • Thompson, Curtis T., MD: no financial relationships exist with commercial interests.
  • Tosti, Antonella, MD: Aclaris Therapeutics, Inc. – A(H); Anacor Pharmaceuticals, Inc. – A(H); DS Laboratories – C(Fees); Fotofinder – C(EQ); Incyte Corporation – C(H); Kurt Wolff GmbH & Co. KG – A(H); Kythera – A(H); Meiji Seika Pharma Co., Ltd – A(H); MSD – SP(H); Novartis – A(H); PharmaDerm – Speaker/Faculty Education(H); Pierre Fabre Dermatologie – C(H); Polichem SA – A(H); Procter & Gamble Company – A(H); Springer Science & Business Media – O(IP); Taylor & Francis – O(IP); topica – C(Fees); Valeant Pharmaceuticals International – C(Fees); Viamet Pharmaceuticals, Inc – A(H);
  • Yost, John, MD: no financial relationships exist with commercial interests.
  • Zubek, Amanda Elisabeth, MD, PhD: no financial relationships exist with commercial interests.
Schedule
Friday, February 16
1:00 PM
Dr. Thompson / Use of Cutting Edge Diagnostic Methods for Onychomycosis
1:10 PM
Dr. Rigopoulos / Onychomycosis and nail psoriasis: are they related, or just a coincidence?
1:20 PM
Dr. Starace / Natural history of isolated nail psoriasis and its role as a risk factor for the development of psoriatic arthritis
1:30 PM
Dr. Baran / Yellow Nail Syndrome: Our Current State of Knowledge
1:40 PM
Dr. Starace / Use of Dermoscopy for Nail Melanoma
1:50 PM
Dr. Thompson, Dr. Rigopoulos, Dr. Starace, Dr. Piraccini, and Dr. Baran / Questions and Answers
2:00 PM
Dr. Ruben / Advanced Imaging Techniques for Melanonychia
2:10 PM
Dr. Lee / Update on diagnosis and molecular testing of melanocytic lesions of the nail unit
2:20 PM
Dr. Jellinek / Insights into Diagnosis and Management of Glomus Tumors Affecting The Nail Unit
2:30 PM
Dr. Zubek / Scientific Insights into Challenging Nail Disorders: the Delivery Challenge
2:40 PM
Dr. Knackstedt / Hot Topics in Nail Surgery
2:50 PM
Dr. Ruben, Dr. Lee, Dr. Zubek, Dr. Knackstedt, and Dr. Jellinek / Questions and Answers
3:00 PM
Dr. Rich / My Great Nail Case That Taught A Lesson
3:08 PM
Dr. Shemer / My Great Nail Case That Taught A Lesson
3:16 PM
Dr. Lipner / My Great Nail Case That Taught A Lesson
3:24 PM
Dr. Adigun / My Great Nail Case That Taught A Lesson
3:32 PM
Dr. Yost / My Great Nail Case That Taught A Lesson
3:40 PM
Dr. Tosti / The Intersection of Contact Dermatitis and Nails: What’s New
3:50 PM
Dr. Rich, Dr. Lipner, Dr. Tosti, Dr. Shemer, Dr. Adigun, and Dr. Yost / Questions and Answers
Event Details
  • Date
    Friday, February 16
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 8
  • CME Credits
    3.00
  • Type
Directors/Co-Directors
  • Adam Rubin, MD, FAAD
Speakers
  • Amanda Elisabeth Zubek, MD, PhD, FAAD
  • Antonella Tosti, MD - Handout
  • Avner Shemer, MD - Handout
  • Beth S. Ruben, MD, FAAD - Handout
  • Chris Adigun, MD, FAAD
  • Curtis T. Thompson, MD
  • Dimitris Rigopoulos, MD
  • Dong-Youn Lee, MD, PhD
  • John Yost, MD, FAAD
  • Michela Starace, MD, PhD
  • Nathaniel J. Jellinek, MD, FAAD
  • Phoebe Rich, MD, FAAD
  • Robert L. Baran, MD
  • Shari Lipner, MD, PhD, FAAD
  • Thomas Joachim Knackstedt, MD, FAAD